We recently compiled a list of the 10 Best Internet of Things (IoT) Stocks to Buy. In this article, we are going to take a ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

TRIB announces positive results from its pre-pivotal clinical European trial for a next-gen continuous glucose monitor, ...

It's the top-selling CGM device in the world ... As is the case with most investing questions, the best answer about whether you should invest in medical device companies is: It depends.

Over the past five years, diabetes-focused medical device specialist DexCom (NASDAQ: DXCM) has made meaningful progress on ...

16,20 However, some uncertainties remain on duration of CGM data, completeness of data, and how to best handle data loss. No device is perfect and there will inevitably be some data points lost over a ...

Continuous glucose monitors (CGM), once exclusive to diabetics, are now available over-the-counter, opening new possibilities ...

DexCom, Inc. (NASDAQ:DXCM) has also consistently beat EPS estimates in the last 4 quarters. The stock has received an average ...

Multiple CGM devices are available worldwide and are marketed, in part, based on accuracy data. In this Viewpoint, we argue that accuracy metrics are no longer a point of difference between CGM ...

Continuous glucose monitoring (CGM) devices show blood sugar trends over time ... As in other areas of diabetes care, use the approach that works best for you and your provider, which can lead to a ...